Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-04-042504
Filing Date
2004-03-16
Accepted
2004-03-15 19:08:18
Documents
11
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 803567
3 SUBSIDIARIES OF THE COMPANY dex211.htm EX-21.1 2771
4 CONSENT OF ERNST & YOUNG dex231.htm EX-23.1 1895
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER SECTION 302 dex311.htm EX-31.1 7042
6 CERTIFICATION OF CHIEF FINANCIAL OFFICER SECTION 302 dex312.htm EX-31.2 6969
7 CERTIFICATION OF CHIEF EXECUTIVE AND CHIEF FINANCIAL OFFICER SECTION 906 dex321.htm EX-32.1 5640
8 GRAPHIC g56863g19z10.jpg GRAPHIC 88980
9 GRAPHIC g56863g25e10.jpg GRAPHIC 70946
10 GRAPHIC g56863g40b41.jpg GRAPHIC 66230
11 GRAPHIC g56863g49q72.jpg GRAPHIC 82270
12 GRAPHIC g56863g71o60.jpg GRAPHIC 65610
  Complete submission text file 0001193125-04-042504.txt   1204827
Mailing Address 125 SUMMER STREET BOSTON MA 02110
Business Address 125 SUMMER STREET BOSTON MA 02110 6179332130
POINT THERAPEUTICS INC (Filer) CIK: 0000919745 (see all company filings)

EIN.: 043216862 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23776 | Film No.: 04670935
SIC: 2834 Pharmaceutical Preparations